A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment

Completed · Phase 1

Conditions studied: Advanced Solid Tumors

In brief

Study to evaluate the safety, tolerability, and pharmacokinetics of TAS-102 in patients with advanced solid tumors and varying degrees of hepatic impairment.

Key facts

Study ID

NCT02301104

Run by

Taiho Oncology, Inc.

People needed

24

Starts

2015-01-01

Expected to finish

2016-06-01

Last updated by the study team

2024-09-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Mayo Clinic — Scottsdale, Arizona, United States
• Duarte Clinical Site — Duarte, California, United States
• Santa Monica Clinical Site — Santa Monica, California, United States
• Baltimore Clinical Site — Baltimore, Maryland, United States
• Boston Clinical Site — Boston, Massachusetts, United States
• Cleveland Clinical Site — Cleveland, Ohio, United States
• Pittsburgh Clinical Site — Pittsburgh, Pennsylvania, United States
• Dallas Clinical Site — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.